Affiliation:
1. N.N. Blokhin National Medical Research Center of Oncology
2. N.N. Blokhin National Medical Research Center of Oncology;
National Research Nuclear University MEPhI
3. National Research Nuclear University MEPhI
Abstract
Purpose: To evaluate the quality of radiation planning for breast cancer patients with implants with a built-in metal port. Conduct a quantitative analysis of the quality of planning, assess the dose load on critical organs for this category of patients.Material and methods: Homogeneity and conformity indices were calculated, and dose loads in critical organs were assessed for irradiation plans using 3D conformal RT (3D CRT) technology for 23 breast cancer patients with a built-in metal port implants. Calculations were carried out both taking into account (outlining) the metal port and artifacts from it on CT images, and without taking it into account.Results: Based on the results of the analysis of the calculated values of conformity and homogeneity indices, doses in critical organs of irradiation plans for 23 patients with breast cancer, it was shown that the presence of a metal port and artifacts from it affects the nature of the dose distribution.Conclusions: When creating a 3D CRT treatment plan, it is necessary to delineate the metal port and artifacts and assign true densities.
Publisher
Non-profit partnership Society of Interventional Oncoradiologists
Reference19 articles.
1. Kaprin AD, Starinsky VV, Shakhzadova AO. The state of cancer care for the population of Russia in 2021. Moscow. 2022; 239. (In Russ.).
2. Rasskazova EA. Modern principles of breast cancer treatment. Doctor. 2017;5:5-8. (In Russ.).
3. Plastic Surgery 2020. Statistics Report. American Society of Plastic Surgeons, 2020.
4. Letyagin VP, Grigorieva TA. Reconstructive plastic surgery in the treatment of patients with breast cancer. Tumors of the female reproductive system. 2013;1:6-14 (In Russ.). https://doi.org/10.17650/1994-4098-2012-0-2-19-26
5. Jonczyk M, Jean J, Graham R. Surgical trends in breast cancer: a rise in novel operative treatment options over a 12- year analysis. Breast Cancer Res Treat. 2019;173(2):267-74.